Yumiko Azuma

878 citations

33 papers · 487 indexed · h-index 14

Neurology top 10%
- Amyotrophic Lateral Sclerosis Research 9
Genetics top 10%
- Neurogenetic and Muscular Disorders Research 6
Neurology
- Amyotrophic Lateral Sclerosis Research 9
Aging
Immunology
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 7
Molecular Biology
- Glycosylation and Glycoproteins Research 3
Rheumatology
- Glycogen Storage Diseases and Myoclonus 3
Oncology
- CAR-T cell therapy research 3
- Cancer Immunotherapy and Biomarkers 3
Cellular and Molecular Neuroscience
- Hereditary Neurological Disorders 3

Co-authors: Takahiko Tokuda Toshiki Mizuno Masamitsu Yamaguchi Masanori Nakagawa Ikuko Mizuta Hideki Yoshida Yoshitaka Nagai Hisafumi Yamada‐Okabe
Cited by: Neurology Genetics
Partner nations: Japan United States Qatar

In The Last Decade

Yumiko Azuma

33 papers receiving 476 citations

Peers

Countries citing papers authored by Yumiko Azuma

Since Specialization

Citations

This map shows the geographic impact of Yumiko Azuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yumiko Azuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yumiko Azuma more than expected).

Fields of papers citing papers by Yumiko Azuma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yumiko Azuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yumiko Azuma. The network helps show where Yumiko Azuma may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yumiko Azuma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yumiko Azuma Line = papers co-authored together Yumiko Azuma links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Genetic screening of the genes interacting with Drosophila FIG4 identified a novel link between CMT-causing gene and long noncoding RNAs Yuuka Muraoka,Aya Nakamura,Ryo Tanaka,Kojiro Suda,Yumiko Azuma,Yukie Kushimura,Luca Lo Piccolo,Hideki Yoshida,Ikuko Mizuta,Takahiko Tokuda,Toshiki Mizuno,Masanori Nakagawa,Masamitsu Yamaguchi	2018	27
2	Novel roles of Drosophila FUS and Aub responsible for piRNA biogenesis in neuronal disorders Keiko Tsuji Wakisaka,Ryo Tanaka,Tomoki Hirashima,Yuuka Muraoka,Yumiko Azuma,Hideki Yoshida,Takahiko Tokuda,Satoshi Asada,Kojiro Suda,Kenji Ichiyanagi,Seiko Ohno,Masanobu Itoh,Masamitsu Yamaguchi	2018	18
3	NPM-hMLF1 fusion protein suppresses defects of a Drosophila FTLD model expressing the human FUS gene Itaru Yamamoto,Yumiko Azuma,Yukie Kushimura,Hideki Yoshida,Ikuko Mizuta,Toshiki Mizuno,Morio Ueyama,Yoshitaka Nagai,Takahiko Tokuda,Masamitsu Yamaguchi	2018	3
4	Amyotrophic Lateral Sclerosis Model Yumiko Azuma,Ikuko Mizuta,Takahiko Tokuda,Toshiki Mizuno	2018	10
5	Novel Drosophila model for mitochondrial diseases by targeting of a solute carrier protein SLC25A46 Kojiro Suda,Ibuki Ueoka,Yumiko Azuma,Yuuka Muraoka,Hideki Yoshida,Masamitsu Yamaguchi	2018	19
6	Loss-of-function mutation in Hippo suppressed enlargement of lysosomes and neurodegeneration caused by dFIG4 knockdown Yukie Kushimura,Yumiko Azuma,Ikuko Mizuta,Yuuka Muraoka,Akane Kyotani,Hideki Yoshida,Takahiko Tokuda,Toshiki Mizuno,Masamitsu Yamaguchi	2018	6
7	Hippo, Drosophila MST, is a novel modifier of motor neuron degeneration induced by knockdown of Caz, Drosophila FUS Yumiko Azuma,Takahiko Tokuda,Yukie Kushimura,Itaru Yamamoto,Ikuko Mizuta,Toshiki Mizuno,Masanori Nakagawa,Morio Ueyama,Yoshitaka Nagai,Yasushi Iwasaki,Mari Yoshida,Duojia Pan,Hideki Yoshida,Masamitsu Yamaguchi	2018	16
8	Abstract 5609: ERY974, a novel T cell-redirecting bispecific antibody targeting glypican-3, shows antitumor activity in gastric cancer patient-derived xenograft models with varying glypican-3 expression Yumiko Azuma,Yuji Sano,Toshiaki Tsunenari,Yasuko Kinoshita,Yoko Miyazaki,Junko Shinozuka,Etsuko Fujii,Atsuhiko Kato,Takahiro Ishiguro,Shohei Kishishita,Jun‐ichi Nezu,Yoshiki Kawabe,Mika Endo	2018	2
9	Loss of function mutant of ter94, Drosophila VCP, partially enhanced motor neuron degeneration induced by knockdown of TBPH, Drosophila TDP-43 Yukie Kushimura,Takahiko Tokuda,Yumiko Azuma,Ikuo Yamamoto,Hideki Yoshida,Ikuko Mizuta,Morio Ueyama,Yoshitaka Nagai,M. Nakagawa,Toshiki Mizuno,Masamitsu Yamaguchi	2017	1
10	Early-onset parkinsonism in a pedigree with phosphoglycerate kinase deficiency and a heterozygous carrier: do PGK-1 mutations contribute to vulnerability to parkinsonism? Satoshi Sakaue,Takashi Kasai,Ikuko Mizuta,Masaya Suematsu,Shinya Osone,Yumiko Azuma,Toshihiko Imamura,Takahiko Tokuda,Hitoshi Kanno,Omar M. A. El‐Agnaf,Masafumi Morimoto,Masanori Nakagawa,Hajime Hosoi,Toshiki Mizuno	2017	40
11	Knockdown of the Drosophila FIG4 induces deficient locomotive behavior, shortening of motor neuron, axonal targeting aberration, reduction of life span and defects in eye development Akane Kyotani,Yumiko Azuma,Itaru Yamamoto,Hideki Yoshida,Ikuko Mizuta,Toshiki Mizuno,Masanori Nakagawa,Takahiko Tokuda,Masamitsu Yamaguchi	2015	30
12	Genetic link between Cabeza, a Drosophila homologue of Fused in Sarcoma (FUS), and the EGFR signaling pathway Mai Shimamura,Akane Kyotani,Yumiko Azuma,Hideki Yoshida,Thanh Nguyen,Ikuko Mizuta,Tomokatsu Yoshida,Toshiki Mizuno,Masanori Nakagawa,Takahiko Tokuda,Masamitsu Yamaguchi	2014	18
13	Identification of ter94, Drosophila VCP, as a strong modulator of motor neuron degeneration induced by knockdown of Caz, Drosophila FUS Yumiko Azuma,Takahiko Tokuda,Mai Shimamura,Akane Kyotani,Hiroshi Sasayama,Tomokatsu Yoshida,Ikuko Mizuta,Toshiki Mizuno,Masanori Nakagawa,Nobuhiro Fujikake,Morio Ueyama,Yoshitaka Nagai,Masamitsu Yamaguchi	2014	36
14	Sixty Six–Month Follow-up of Muscle Power and Respiratory Function in a Case With Adult-Type Pompe Disease Treated With Enzyme Replacement Therapy Reina Isayama,Kensuke Shiga,Kazuya SEO,Yumiko Azuma,Yasukiyo Araki,Ai Hamano,Hedesato Takezawa,Nagato Kuriyama,Nobuo Takezawa,Toshiki Mizuno,Masanori Nakagawa	2014	5
15	Knockdown of the Drosophila Fused in Sarcoma (FUS) Homologue Causes Deficient Locomotive Behavior and Shortening of Motoneuron Terminal Branches Hiroshi Sasayama,Mai Shimamura,Takahiko Tokuda,Yumiko Azuma,Tomokatsu Yoshida,Toshiki Mizuno,Masanori Nakagawa,Nobuhiro Fujikake,Yoshitaka Nagai,Masamitsu Yamaguchi	2012	61
16	Extraischemic cerebral hematomas of the cerebellum in an extremely elderly stroke patient treated with intravenous rt-PA therapy: A case report Hidesato Takezawa,Keisuke Imai,Masashi Hamanaka,Masahiro Makino,Daisuke Maruyama,Yumiko Azuma,Fumiko Oshima,Kenichiro Oda	2010	1
17	A case report of HTLV-I associated myelopathy presenting with cerebellar ataxia and nystagmus Masakatsu Taki,Fumiaki Nin,Tatsuhisa Hasegawa,Hirofumi Sakaguchi,Toshihiro Suzuki,Yasuo Hisa,Yumiko Azuma,Masanori Nakagawa	2010	3
18	Interferon‐α enhances CD317 expression and the antitumor activity of anti‐CD317 monoclonal antibody in renal cell carcinoma xenograft models Shigeto Kawai,Yumiko Azuma,Etsuko Fujii,Kou Furugaki,Shuji Ozaki,Toshio Matsumoto,Masaaki Kosaka,Hisafumi Yamada‐Okabe	2008	39
19	Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia Shinsuke Uno,Yasuko Kinoshita,Yumiko Azuma,Toshiaki Tsunenari,Yasushi Yoshimura,Shinichiro Iida,Yasufumi Kikuchi,Hisafumi Yamada‐Okabe,Naoshi Fukushima	2007	45
20	2D7 diabody bound to the α2 domain of HLA class I efficiently induces caspase-independent cell death against malignant and activated lymphoid cells Naoki Kimura,Shigeto Kawai,Yasuko Kinoshita,Takahiro Ishiguro,Yumiko Azuma,Shuji Ozaki,Masahiro Abe,Masamichi Sugimoto,Yuichi Hirata,Tetsuro Orita,Hisafumi Okabe,Toshio Matsumoto,Masayuki Tsuchiya	2004	8

About Yumiko Azuma

Yumiko Azuma is a scholar working on Neurology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 33 papers that have together received 487 indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Neurogenetic and Muscular Disorders Research (6 papers), Glycosylation and Glycoproteins Research (3 papers), Glycogen Storage Diseases and Myoclonus (3 papers), CAR-T cell therapy research (3 papers), Hereditary Neurological Disorders (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Neurology (173 citations), Genetics (84 citations) and Neurology (47 citations). Yumiko Azuma has collaborated with scholars based in Japan, United States and Qatar. Frequent co-authors include Takahiko Tokuda, Toshiki Mizuno, Masamitsu Yamaguchi, Masanori Nakagawa, Ikuko Mizuta, Hideki Yoshida, Yoshitaka Nagai, Hisafumi Yamada‐Okabe, Tomokatsu Yoshida and Nobuhiro Fujikake.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact